Blasco Maria A
Telomeres and Telomerase Group, Molecular Oncology Program, Spanish National Cancer Centre (CNIO), 28029 Madrid, Spain.
Nat Rev Genet. 2005 Aug;6(8):611-22. doi: 10.1038/nrg1656.
Telomere length and telomerase activity are important factors in the pathobiology of human disease. Age-related diseases and premature ageing syndromes are characterized by short telomeres, which can compromise cell viability, whereas tumour cells can prevent telomere loss by aberrantly upregulating telomerase. Altered functioning of both telomerase and telomere-interacting proteins is present in some human premature ageing syndromes and in cancer, and recent findings indicate that alterations that affect telomeres at the level of chromatin structure might also have a role in human disease. These findings have inspired a number of potential therapeutic strategies that are based on telomerase and telomeres.
端粒长度和端粒酶活性是人类疾病病理生物学中的重要因素。与年龄相关的疾病和早衰综合征的特征是端粒较短,这会损害细胞活力,而肿瘤细胞可以通过异常上调端粒酶来防止端粒丢失。端粒酶和端粒相互作用蛋白的功能改变存在于一些人类早衰综合征和癌症中,最近的研究结果表明,在染色质结构水平上影响端粒的改变也可能在人类疾病中起作用。这些发现激发了一些基于端粒酶和端粒的潜在治疗策略。